These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 8946937

  • 1. In vitro cytotoxicity of 2-chlorodeoxyadenosine and chlorambucil in chronic lymphocytic leukemia.
    Begleiter A, Wang H, Verburg L, Lee K, Israels LG, Mowat MR, Johnston JB.
    Leukemia; 1996 Dec; 10(12):1959-65. PubMed ID: 8946937
    [Abstract] [Full Text] [Related]

  • 2. Comparison of antitumor activities of 2-chlorodeoxyadenosine and 9-beta-arabinosyl-2-fluoroadenine in chronic lymphocytic leukemia and marrow cells in vitro.
    Begleiter A, Verburg L, Ashique A, Lee K, Israels LG, Mowat MR, Johnston JB.
    Leukemia; 1995 Nov; 9(11):1875-81. PubMed ID: 7475278
    [Abstract] [Full Text] [Related]

  • 3. In vitro sensitivity of chronic lymphocytic leukemia B-cells to fludarabine, 2-chlorodeoxyadenosine and chlorambucil: correlation with clinico-hematological and immunophenotypic features.
    Morabito F, Stelitano C, Callea I, Filangeri M, Oliva B, Sculli G, Callea V, Nobile F, Brugiatelli M.
    Haematologica; 1996 Nov; 81(3):224-31. PubMed ID: 8767527
    [Abstract] [Full Text] [Related]

  • 4. Combination therapy with nucleoside analogs and alkylating agents.
    Johnston JB, Verburg L, Shore T, Williams M, Israels LG, Begleiter A.
    Leukemia; 1994 Apr; 8 Suppl 1():S140-3. PubMed ID: 8152282
    [Abstract] [Full Text] [Related]

  • 5. Bcl-2 protein expression and p53 gene mutation in chronic lymphocytic leukemia: correlation with in vitro sensitivity to chlorambucil and purine analogs.
    Morabito F, Filangeri M, Callea I, Sculli G, Callea V, Fracchiolla NS, Neri A, Brugiatelli M.
    Haematologica; 1997 Apr; 82(1):16-20. PubMed ID: 9107076
    [Abstract] [Full Text] [Related]

  • 6. Sequential treatment of human chronic lymphocytic leukemia with bryostatin 1 followed by 2-chlorodeoxyadenosine: preclinical studies.
    Mohammad RM, Katato K, Almatchy VP, Wall N, Liu KZ, Schultz CP, Mantsch HH, Varterasian M, al-Katib AM.
    Clin Cancer Res; 1998 Feb; 4(2):445-53. PubMed ID: 9516935
    [Abstract] [Full Text] [Related]

  • 7. Chlorambucil synergizes with purine analogs in inducing in vitro cytotoxicity in B-cell chronic lymphocytic leukemia.
    Callea I, Console G, Sculli G, Filangeri M, Messina G, Morabito F.
    Haematologica; 1998 Aug; 83(8):756-7. PubMed ID: 9793266
    [Abstract] [Full Text] [Related]

  • 8. Imatinib sensitizes CLL lymphocytes to chlorambucil.
    Aloyz R, Grzywacz K, Xu ZY, Loignon M, Alaoui-Jamali MA, Panasci L.
    Leukemia; 2004 Mar; 18(3):409-14. PubMed ID: 14712290
    [Abstract] [Full Text] [Related]

  • 9. Comparison of infrared spectra of CLL cells with their ex vivo sensitivity (MTT assay) to chlorambucil and cladribine.
    Liu KZ, Schultz CP, Johnston JB, Lee K, Mantsch HH.
    Leuk Res; 1997 Mar; 21(11-12):1125-33. PubMed ID: 9444947
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Chlorambucil induction of HsRad51 in B-cell chronic lymphocytic leukemia.
    Christodoulopoulos G, Malapetsa A, Schipper H, Golub E, Radding C, Panasci LC.
    Clin Cancer Res; 1999 Aug; 5(8):2178-84. PubMed ID: 10473103
    [Abstract] [Full Text] [Related]

  • 13. P53, MDM-2, BAX and BCL-2 and drug resistance in chronic lymphocytic leukemia.
    Johnston JB, Daeninck P, Verburg L, Lee K, Williams G, Israels LG, Mowat MR, Begleiter A.
    Leuk Lymphoma; 1997 Aug; 26(5-6):435-49. PubMed ID: 9389352
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Evaluation of apoptosis induced in vitro by cladribine (2-CdA) combined with anthracyclines in lymphocytes from patients with B-cell chronic lymphocytic leukemia.
    Szmigielska-Kaplon A, Smolewski P, Najder M, Robak T.
    Ann Hematol; 2002 Sep; 81(9):508-13. PubMed ID: 12373351
    [Abstract] [Full Text] [Related]

  • 16. Chlorambucil in chronic lymphocytic leukemia: mechanism of action.
    Begleiter A, Mowat M, Israels LG, Johnston JB.
    Leuk Lymphoma; 1996 Oct; 23(3-4):187-201. PubMed ID: 9031099
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Cross-resistance and synergy with bendamustine in chronic lymphocytic leukemia.
    Kost SE, Bouchard ED, LaBossière É, Ye X, Queau ML, Liang WS, Banerji V, Gibson SB, Katyal S, Johnston JB.
    Leuk Res; 2016 Nov; 50():63-71. PubMed ID: 27683974
    [Abstract] [Full Text] [Related]

  • 19. Role of the TRAIL/APO2-L death receptors in chlorambucil- and fludarabine-induced apoptosis in chronic lymphocytic leukemia.
    Johnston JB, Kabore AF, Strutinsky J, Hu X, Paul JT, Kropp DM, Kuschak B, Begleiter A, Gibson SB.
    Oncogene; 2003 Nov 13; 22(51):8356-69. PubMed ID: 14614459
    [Abstract] [Full Text] [Related]

  • 20. Pentostatin (Nipent) and chlorambucil with granulocyte-macrophage colony-stimulating factor support for patients with previously untreated, treated, and fludarabine-refractory B-cell chronic lymphocytic leukemia.
    Waselenko JK, Grever MR, Beer M, Lucas MA, Byrd JC.
    Semin Oncol; 2000 Apr 13; 27(2 Suppl 5):44-51. PubMed ID: 10877052
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.